title: Comparative Efficacy And Tolerability Of Solifenacin 5mg Versus Oral Antimuscarinic Agents In Overactive Bladder (Oab): A Systematic Literature Review (Slr) And Mixed Treatment Comparison (Mtc).
authors.affiliation: Guy's and St. Thomas' NHS Foundation Trust, London, UK.
authors.forename: C
authors.initials: C
authors.lastname: Kelleher
authors.affiliation: Creativ-Ceutical, Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Aballea
authors.affiliation: Creativ Ceutical, Paris, France.
authors.forename: K
authors.initials: K
authors.lastname: Maman
authors.affiliation: Astellas Pharma Europe Ltd, Chertsey, UK.
authors.forename: J
authors.initials: J
authors.lastname: Nazir
authors.affiliation: Astellas Pharma Global Development, Leiden, The Netherlands.
authors.forename: Z
authors.initials: Z
authors.lastname: Hakimi
authors.affiliation: Astellas Pharma Europe Ltd, Chertsey, UK.
authors.forename: C
authors.initials: C
authors.lastname: Chambers
authors.affiliation: Astellas Pharma Europe Ltd, Chertsey, UK.
authors.forename: I A
authors.initials: IA
authors.lastname: Odeyemi